Literature DB >> 29268792

Individual diseases or clustering of health conditions? Association between multiple chronic diseases and health-related quality of life in adults.

David Alejandro González-Chica1, Catherine L Hill2, Tiffany K Gill3, Phillipa Hay4, Dandara Haag5, Nigel Stocks6.   

Abstract

BACKGROUND: Chronic diseases are highly prevalent and cluster in individuals (multimorbidity). This study investigated the association between multimorbidity and Health-Related Quality of Life (HRQoL), assessing the combination of chronic diseases highly correlated with this outcome.
METHODS: We conducted a household survey in 2015 in a random sample of 2912 South Australian adults (48.9 ± 18.1 years; 50.9% females), obtaining information on sociodemographics, lifestyle, and 17 chronic conditions clustered in four different groups (metabolic, cardiovascular, gastrointestinal, and musculoskeletal). Information on physical (PCS) and mental components scores (MCS) of HRQoL were assessed using the SF-12 questionnaire. Multivariable linear regression models considering individual diseases (mutually adjusted) and clusters within- and between-groups were used to test the associations.
RESULTS: Only 41% of the sample was negative for all the investigated diseases. The most prevalent conditions were osteoarthritis, obesity and hypertension, which affected one in every four individuals. PCS was markedly lower among those reporting stroke, heart failure, and osteoarthritis, but they were not associated with MCS. Direct-trend relationships were observed between the number of chronic conditions (clusters within- and between-groups) and PCS, but not with MCS. The strongest association with PCS was for musculoskeletal conditions (difference between those affected by 2+ conditions and those free of these conditions -6.7 95%CI -8.5;-5.4), and lower PCS were observed in any combination of clusters between-group including musculoskeletal diseases.
CONCLUSION: In the context of multimorbidity, musculoskeletal diseases are a key determinant group of PCS, amplifying the association of other chronic conditions on physical but not on mental health.

Entities:  

Keywords:  Chronic disease; Epidemiologic methods; Multimorbidity; Multiple chronic conditions; Quality of life

Mesh:

Year:  2017        PMID: 29268792      PMCID: PMC5740772          DOI: 10.1186/s12955-017-0806-6

Source DB:  PubMed          Journal:  Health Qual Life Outcomes        ISSN: 1477-7525            Impact factor:   3.186


Background

Non-communicable chronic diseases (NCDs) are the leading cause of mortality, being responsible for 68% of all deaths (38 million) worldwide in 2012. The proportional mortality related to NCDs is greater in high-income countries, where they account for 87% of all deaths, compared to 57% and 37% in middle- and low-income countries, respectively [1]. However, there is a considerable variability in the proportion of deaths attributable to NCDs among high-income countries, ranging from less than 80% in Asiatic countries to more than 90% in some European countries (Finland, Switzerland, Germany, Italy) and Australia [2]. Moreover, NCDs are also related to a substantial burden for individuals and society, due to their long-lasting effect on health status, frequent health care utilisation, loss of productivity, and reduced health-related quality of life (HRQoL) [3-5]. HRQoL is a patient-centered outcome that assesses the impact of health conditions on daily living, based on the self-perception of the individuals, and considers their social and cultural context [4, 6]. Several studies performed in clinical settings have reported different NCDs negatively affect HRQoL [4]. However, few population-based studies have examined whether some combinations of NCDs are more correlated with this outcome [7, 8]. To investigate the relationship between multimorbidity (clusters of different NCDs affecting the same individual) [5] and the different domains of HRQoL is particularly relevant for public health purposes, considering this outcome is closely related to the adherence to health management, hospitalisations, and mortality [6, 9]. Furthermore, in the last decades, there has been a progressive rise in the prevalence of NCDs and multimorbidity [2, 3]. Although the increase in life expectancy is one of the reasons for this change, other aspects seem to contribute to multimorbidity. Firstly, various NCDs share similar risk factors, such as smoking, inadequate diets, excessive alcohol intake, and stress [5], and some of them have also increased in the last few years [2, 3]. Secondly, unhealthy habits are more likely to occur together, increasing the vulnerability to multiple health conditions [10]. Finally, NCDs tend to generate an overall state of immune suppression and/or inflammation, increasing the risk of developing other chronic diseases [5]. Understanding the relationship between clusters of NCDs and HRQoL could assist health policy makers to identify chronic disease combinations highly correlated with this outcome, as they might be useful for developing preventive strategies and improving clinical guidelines [6, 9, 11]. This is particularly relevant considering that clinical guidelines are usually created for the management of specific diseases and rarely account for multimorbidity [12]. The aim of this study was to investigate the association between chronic health conditions (individual diseases and clusters within- and between-groups) and HRQoL (physical and mental domains) among adults living in South Australia.

Methods

This is a cross-sectional study using face-to-face interviews, including a representative sample of adults living in South Australia (SA) in 2015. SA has approximately 1.7 million inhabitants (73% living in the capital), a life expectancy of 83.0 years, and a very high human development index of 0.907 (composite index of life expectancy, education, and per capita income indicators), equivalent to that of Sweden and the UK [13]. Details of the methodology have been published elsewhere [14, 15]. In summary, a multistage sampling process was used to select individuals. Firstly, cities/localities were stratified according to their location (metropolitan or rural). Secondly, 530/3939 Statistical Areas Level 1 (SA1 i.e. the smallest division unit used in the Australian census in 2011) [13] were systematically selected (selection probability proportional to their size). Thirdly, clusters of 10 residences were systematically selected in each SA1. Finally, one dweller aged 15+ years was randomly chosen (last person to have a birthday) in each of the selected households. Individuals were excluded if terminally ill/mental incapacitated (n = 104) or unable to speak English (n = 87). Of the 4226 eligible participants, 1221 refused to answer the survey, providing a final sample of 3005 individuals (71.1%). For the purposes of this paper, only individuals aged 20+ years were included in the analyses (N = 2912).

Patient-centered outcome

The patient-centered tool used in this study was the Medical Outcomes Study Short Form 12 (SF-12v1). The 12 questions in this instrument evaluate HRQoL in the past four weeks, generating two different 0–100 component scores (physical (PCS) and mental (MCS)), with higher values indicating a better HRQoL [16-18]. The SF-12v1 is an instrument with good psychometric properties, including test-retest reliability coefficients of 0.9 for PCS and 0.8 for MCS, and appropriate construct validity (relative validity of 0.93 for PCS and 1.1 for MCS in the discrimination of groups of patients who differ in physical and mental health according to proven clinical measures) [18].

Multimorbidity and clusters of chronic conditions

The diagnosis of clinical conditions was based on the medical diagnosis (“have you ever been told by a doctor that you have…”) and/or treatment (“are you on medication for…”) for 17 chronic conditions, classified as 1) metabolic (obesity, diabetes, dyslipidaemia); 2) cardiovascular (hypertension, myocardial infarction, angina, heart failure, atrial fibrillation/arrhythmia, stroke); 3) gastrointestinal (gastroesophageal reflux, irritable bowel syndrome, Crohn’s disease, ulcerative colitis, and/or coeliac disease), and; 4) musculoskeletal (osteoarthritis, gout, osteoporosis). Obesity was defined as a body mass index ≥30 kg/m2 [19] and investigated based on self-reported weight and height. Clustering within-group was assessed by counting the number of health conditions in each group (metabolic, cardiovascular, gastrointestinal, and musculoskeletal). For the clusters between-group, the counts of chronic conditions within each group were transformed into binary variables (none or 1+ condition in the correspondent group). The four binary variables were then combined to create 16 possible combinations: negatives for all conditions, positives for just one group (4 possibilities), two-group clusters (6 possible combinations), three-group clusters (4 possible combinations), and positives for all the groups.

Confounding variables

Sociodemographic, lifestyle, and mental health status variables were included as possible confounders of the tested associations, as they are associated with the occurrence of chronic conditions and correlated with HRQoL [20-23]. These variables included gender (male or female), age (in years, including a quadratic term for non-linear associations), marital status (married/living with a partner - yes or no), residence area (urban or rural), attained educational level (bachelor or higher; trade qualification; certificate/diploma; secondary; less than secondary), working status (employed full-time; employed part-time; unemployed; retired), and macro-level socioeconomic position. Macro-level socioeconomic position was investigated using the 2011 Australian Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantage (SEIFA-IRSAD). This index is based on a range of census variables and is an indicator of relative economic and social advantage/disadvantage of people and households within an area [24], with high scores indicating the respondent residing in a more advantaged area. Lifestyle variables included daily fruit/vegetable consumption (0–2, 3–4, or 5+ portions/day), weekly practice of 30+ minutes of moderate/vigorous physical activity (0–1, 2–4, or 5+ days/week), daily alcohol consumption (0–2, 3–4, or 5+ standard drinks/day), and smoking status (never, former, or current smoker). Individuals were considered positives for a mental health condition when they referred receiving treatment for anxiety, depression, or any other mental health problem. Mental health status (“currently receiving treatment for anxiety, depression, or any other health problem”) was also included as a possible confounder, considering the associations could be overestimated among individuals affected by these conditions [20, 25].

Data analysis

Categorical variables were described considering absolute and relative frequencies (%), while mean and standard deviation or median with interquartile range (p25-p75) were used for numerical variables, depending on their symmetry. Linear regression models were used to evaluate the association between chronic conditions (individual, cluster within-groups, and clusters between-groups) and HRQoL. The results were fully adjusted for sociodemographic variables, lifestyle, and mental health status, independently of their p-value in the association with the outcomes (Model 1). Additionally, individual chronic conditions and clusters within-groups were mutually adjusted (Model 2), to take into account the coexistence of the other conditions in the same individual (multimorbidity). Regression coefficients (β) or marginal adjusted means of HRQoL with their respective confidence intervals of 95% (95%CI) were estimated. An alpha of 5% was defined as indicative of statistical significance. Determination coefficients (R2) were used to evaluate the overall model fit, while the variance inflation factor (VIF) was investigated as an indicator of possible collinearity between the explanatory variables. [26] All the analyses were performed in STATA 14.0 (StataCorp, Texas, USA), weighted to the inverse of the individual’s probability of selection within the household, re-weighted to the estimated resident population in SA in 2014 (according to age and sex), and analyzed considering the sampling design (clusters of SA1) [13, 14]. For the analysis of clusters between-group, an additional weight was considered, to account for the number of chronic conditions in each group (probability between-group multiplied by the probability of each condition within the correspondent group). This study was approved by the University of Adelaide Human Research Ethics Committee (project H-097-2010) and participants provided their consent to participate in the survey.

Results

The mean age of the 2912 individuals included in the analyses was 48.9 ± 18.1 years (50.9% females). Participants’ sociodemographic characteristics and lifestyle variables are described in Table 1. The mean PCS (48.4 ± 10.4 points) was lower than MCS (52.4 ± 8.8 points).
Table 1

Sample distribution according to sociodemographic variables among individuals ≥20 years in South Australia, 2015 (unweighted N = 2912)

VariablesNumber of participants (%)
Gender: Females1482 (50.9)
Age group
 20–34 years789 (27.1)
 35–49 years719 (24.7)
 50–64 years757 (26.0)
 65–79 years494 (17.0)
 ≥ 80 years153 (5.3)
Marital status: Married/living with a partner1942 (66.7)
Residence area: Urban2169 (74.5)
Educational level
 Bachelor or higher743 (25.5)
 Trade qualification384 (13.2)
 Certificate/diploma821 (28.2)
 Secondary705 (24.2)
 Less than secondary259 (8.9)
Working status
 Employed full time1083 (37.2)
 Employed part time594 (20.4)
 Not working577 (19.8)
 Retired658 (22.6)
Socioeconomic position (quartiles)a
 High818 (28.1)
 Middle-high646 (22.2)
 Middle-low725 (24.9)
 Low722 (24.8)
Fruit/vegetable consumption (portions/day)
 0–2842 (28.9)
 3–41141 (39.2)
 5+929 (31.9)
Physical activity (days/week)
 0–1864 (29.7)
 2–31050 (36.1)
 5+998 (34.3)
Alcohol intake (doses/day)
 0–21902 (65.3)
 3–4597 (20.5)
 5+413 (14.2)
Smoking status
 Never1226 (42.1)
 Former1229 (42.2)
 Current457 (15.7)

aBased on the Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged (SEIFA-IRSAD)

The weighting of data can lead to rounding effects and totals not adding to 100%

Sample distribution according to sociodemographic variables among individuals ≥20 years in South Australia, 2015 (unweighted N = 2912) aBased on the Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged (SEIFA-IRSAD) The weighting of data can lead to rounding effects and totals not adding to 100% Table 2 presents the prevalence of the 17 independent chronic conditions (divided into four groups) and their association with HRQoL. The most prevalent conditions were osteoarthritis, obesity and hypertension, which affected one in every four individuals. In crude analysis, all the conditions were related to a lower PCS, although the results for ulcerative colitis, Crohn’s disease, and coeliac disease were non-significant. After adjustment for sociodemographic, lifestyle and mental health status variables (Model 1), there was a considerable reduction in the magnitude of the associations (at least 50% reduction for most of the associations), but the statistical significance remained stable. A further reduction of the differences between categories was observed when the chronic conditions were mutually adjusted (Model 2), and only nine conditions remained associated with a lower PCS: obesity, diabetes, atrial fibrillation, stroke, heart failure, gastroesophageal reflux, irritable bowel syndrome, osteoarthritis, and osteoporosis. PCS was markedly lower among those reporting stroke, heart failure, and osteoarthritis. Regarding MCS, only six conditions were associated with a lower score: obesity, hypertension, gastroesophageal reflux, irritable bowel syndrome, and ulcerative colitis. After adjustment for covariates and mutual adjustment for other health conditions (Model 2), only ulcerative colitis, irritable bowel syndrome, and osteoporosis remained related to a lower MCS, with ulcerative colitis showing the strongest association.
Table 2

Association between metabolic, cardiovascular, gastrointestinal, and musculoskeletal conditions with the health related quality of life among individuals ≥20 years in South Australia, 2015 (N = 2912)

%Physical component scoreMental component score
CrudeAdjustedCrudeAdjusted
Model 1Model 2Model 1Model 2
Mean difference (SE)Mean difference (SE)Mean difference (SE)Mean difference (SE)Mean difference (SE)Mean difference (SE)
Metabolic conditions
Obesity*25.3-5.2 (0.5)a −3.6 (0.5)a −2.3 (0.4)a −0.9 (0.4)c −0.3 (0.4)0.0 (0.4)
Dyslipidaemia16.9−7.3 (0.6)a −2.5 (0.6)a −0.3 (0.6)0.3 (0.5)0.0 (0.4)0.0 (0.5)
Diabetes9.3−7.8 (0.7)a −3.7 (0.6)a −2.2 (0.6)b −0.6 (0.6)−0.1 (0.5)−0.2 (0.5)
Cardiovascular conditions
Hypertension22.4−7.6 (0.6)a −2.8 (0.7)a −1.1 (0.6)1.3 (0.4)b 0.8 (0.4)1.0 (0.5)
Heart attack5.2−9.4 (1.0)a −3.7 (1.0)a −1.7 (1.2)0.4 (0.7)−0.8 (0.7)−0.9 (0.8)
Atrial fibrillation3.2−8.4 (1.2)a −4.0 (1.1)a −2.7 (1.0)b 0.9 (0.9)−0.1 (0.9)0.1 (0.9)
Angina2.3−12.1 (1.5)a −5.2 (1.3)a −1.7 (1.2)−1.1 (1.3)−0.4 (1.1)0.2 (1.2)
Stroke1.7−13.0 (1.3)a −6.5 (1.6)a −4.2 (1.7)c −1.7 (1.5)−1.3 (1.5)−1.3 (1.5)
Heart failure1.0−14.9 (1.6)a −9.1 (1.6)a −6.1 (1.5)a 1.0 (1.4)−0.2 (1.3)0.2 (1.4)
Gastrointestinal conditions
Gastroesophageal reflux8.4−6.1 (0.9)a −3.3 (0.7)a −1.7 (0.7)c −2.3 (0.8)b −1.1 (0.7)−0.8 (0.7)
Irritable bowel syndrome7.9−4.7 (0.9)a −2.9 (0.7)a −1.7 (0.7)c −3.3 (0.7)a −1.9 (0.6)b −1.7 (0.6)b
Ulcerative colitis0.9−5.0 (2.6)−2.2 (2.2)−0.9 (1.8)−6.0 (1.7)b −5.0 (1.7)b −4.5 (1.7)b
Crohn’s disease0.8−4.7 (3.1)−3.7 (2.7)−3.0 (2.5)−2.4 (2.4)−1.2 (1.8)−0.1 (1.6)
Coeliac disease0.7−1.7 (2.1)−1.9 (1.6)−1.7 (1.9)−0.6 (0.6)−0.1 (1.1)0.4 (1.1)
Musculoskeletal conditions
Osteoarthritis25.6−10.4 (0.5)a −7.1 (0.5)a −6.1 (0.5)a −0.6 (0.5)0.0 (0.5)0.2 (0.5)
Gout6.1−5.3 (0.9)a −1.9 (0.9)c −0.1 (0.9)0.3 (0.7)−0.9 (0.6)−0.8 (0.6)
Osteoporosis5.2−8.7 (0.9)a −3.1 (0.8)a −2.1 (0.7)b −1.2 (0.8)−1.4 (0.7)−1.5 (0.7)c

*Obesity was defined as having a BMI ≥ 30, based on self-reported data for weight and height

Model 1: predicted means adjusted for sex, age, marital status, area of residence, educational level, working status, socioeconomic position (Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged), fruit/vegetable consumption, physical activity, smoking status, alcohol intake, and mental health status

Model 2: predicted means adjusted for variables in model 1 + mutual adjustment between chronic conditions

Associations with a p-value a < 0.001; b < 0.01; c < 0.05

Crude R2 for PCS and MCS were: Obesity 4.8% and 0.2%; Dyslipidaemia 7.0% and 0.02%; Diabetes 4.7% and 0.04%; Hypertension 9.2% and 0.4%; Heart attack 4.0% and 0.01%; Atrial fibrillation 2.0% and 0.03%; Angina 3.1% and 0.03%; Stroke 2.6% and 0.1%; Heart failure 2.0% and 0.01%; Gastroesophageal reflux 2.7% and 0.5%; Irritable bowel syndrome 1.5% and 1.1%; Ulcerative colitis 0.2% and 0.4%; Chron’s disease 0.2% and 0.1%; Coeliac disease 0.02% and 0.01%; Osteoarthritis 19.2% and 0.1%; Gout 1.5% and 0.01%; Osteoporosis 3.5% and 0.1%. Adjusted R2 for models including just sociodemographic, lifestyle, and mental health status variables were 27.2% for PCS and 23.4% for MCS, while R2 for full models with mutual adjustment of all conditions (Model 2) were 38.1% and 24.4%, respectively

Association between metabolic, cardiovascular, gastrointestinal, and musculoskeletal conditions with the health related quality of life among individuals ≥20 years in South Australia, 2015 (N = 2912) *Obesity was defined as having a BMI ≥ 30, based on self-reported data for weight and height Model 1: predicted means adjusted for sex, age, marital status, area of residence, educational level, working status, socioeconomic position (Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged), fruit/vegetable consumption, physical activity, smoking status, alcohol intake, and mental health status Model 2: predicted means adjusted for variables in model 1 + mutual adjustment between chronic conditions Associations with a p-value a < 0.001; b < 0.01; c < 0.05 Crude R2 for PCS and MCS were: Obesity 4.8% and 0.2%; Dyslipidaemia 7.0% and 0.02%; Diabetes 4.7% and 0.04%; Hypertension 9.2% and 0.4%; Heart attack 4.0% and 0.01%; Atrial fibrillation 2.0% and 0.03%; Angina 3.1% and 0.03%; Stroke 2.6% and 0.1%; Heart failure 2.0% and 0.01%; Gastroesophageal reflux 2.7% and 0.5%; Irritable bowel syndrome 1.5% and 1.1%; Ulcerative colitis 0.2% and 0.4%; Chron’s disease 0.2% and 0.1%; Coeliac disease 0.02% and 0.01%; Osteoarthritis 19.2% and 0.1%; Gout 1.5% and 0.01%; Osteoporosis 3.5% and 0.1%. Adjusted R2 for models including just sociodemographic, lifestyle, and mental health status variables were 27.2% for PCS and 23.4% for MCS, while R2 for full models with mutual adjustment of all conditions (Model 2) were 38.1% and 24.4%, respectively Table 3 displays the frequency of clustering within-groups and their association with HRQoL. Clusters within-group (positives for 2+ conditions of the same group) were more frequent for metabolic conditions (10.7%), followed by cardiovascular (6.9%), musculoskeletal (6.1%), and gastrointestinal conditions (2.1%). An inverse trend association was observed between the number of chronic conditions in each group and PCS in crude and adjusted analysis. In the fully adjusted model (Model 2), the largest difference was for musculoskeletal conditions (difference between those affected by 2+ conditions and those free of these conditions −6.7 95%CI -8.5;-5.4), followed by cardiovascular (−4.6 95%CI -6.5;-2.7), gastrointestinal (−3.7 95%CI -6.3;-1.1), and metabolic conditions (−3.1 95%CI -4.5;-1.8). For MCS, in Model 2 only gastrointestinal conditions remained related to a lower mental score (−3.4 95%CI -5.6;-1.2).
Table 3

Association between clusters intra-groups of metabolic, cardiovascular, cardiovascular, and musculoskeletal conditions with the health related quality of life among individuals ≥20 years in South Australia, 2015 (N = 2912)

Physical component scoreMental component score
(%)CrudeAdjustedCrudeAdjusted
Model 1Model 2Model 1Model 2
Mean (SE)Mean (SE)Mean (SE)Mean (SE)Mean (SE)Mean (SE)
Metabolic conditionsp < 0.001p < 0.001p < 0.001 p = 0.21 p = 0.99 p = 0.90
None61.451.1 (0.3)49.9 (0.2)49.4 (0.2)52.5 (0.2)52.4 (0.2)52.4 (0.2)
127.945.3 (0.4)46.5 (0.4)47.1 (0.3)52.4 (0.4)52.5 (0.3)52.4 (0.3)
2+10.740.8 (0.7)44.7 (0.6)46.3 (0.6)51.7 (0.5)52.4 (0.4)52.3 (0.4)
R 2 12.4% 30.2% 36.9% 0.1% 23.4% 24.1%
Cardiovascular conditionsp < 0.001p < 0.001p < 0.001 p = 0.02 p = 0.51 p = 0.39
None74.050.5 (0.2)49.4 (0.2)49.0 (0.2)52.1 (0.2)52.3 (0.2)52.3 (0.2)
119.144.1 (0.6)46.8 (0.6)47.8 (0.5)53.3 (0.7)53.1 (0.3)53.1 (0.4)
2+6.937.9 (0.8)42.4 (0.9)44.3 (0.9)52.8 (1.1)52.1 (0.6)52.3 (0.6)
R 2 13.2% 29.5% 36.9% 0.3% 23.5% 24.1%
Gastrointestinal conditionsp < 0.001p < 0.001p < 0.001p < 0.001p < 0.001 p = 0.001
None83.649.2 (0.3)48.9 (0.2)48.7 (0.2)52.8 (0.2)52.7 (0.2)52.7 (0.2)
114.344.7 (0.6)46.2 (0.5)46.7 (0.5)50.7 (0.5)51.6 (0.5)51.6 (0.5)
2+2.144.7 (1.6)43.2 (1.3)45.0 (1.3)47.1 (1.5)48.7 (1.1)49.2 (1.1)
R 2 3.8% 28.4% 36.9% 1.5% 23.9% 24.1%
Musculoskeletal conditionsp < 0.001p < 0.001p < 0.001 p = 0.18 p = 0.16 p = 0.34
None69.551.4 (0.2)50.5 (0.2)50.2 (0.2)52.6 (0.2)52.5 (0.2)52.5 (0.2)
124.442.1 (0.4)44.0 (0.4)44.6 (0.4)52.1 (0.5)52.4 (0.4)52.5 (0.4)
2+6.138.9 (0.8)42.1 (0.8)43.2 (0.7)51.7 (0.8)51.2 (0.7)51.4 (0.7)
R 2 20.1% 33.6% 36.9% 0.1% 23.5% 24.1%

Metabolic conditions: obesity, dyslipidaemia, and/or diabetes mellitus. Cardiovascular conditions: hypertension, myocardial infarction, angina, atrial fibrillation, heart failure, and/or stroke. Gastrointestinal conditions: irritable bowel syndrome, gastroesophageal reflux, coeliac disease, Chrohn’s disease and/or ulcerative colitis. Musculoskeletal conditions: osteoarthritis, gout and/or osteoporosis

Model 1: predicted means adjusted for sex, age, marital status, area of residence, educational level, working status, socioeconomic position (Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged), fruit/vegetable consumption, physical activity, smoking status, alcohol intake, and mental health status

Model 2: predicted means adjusted for variables in model 1 + mutual adjustment between the cluster intragroup of chronic conditions

R2 = Determination coefficient in %. Adjusted R2 for models including just sociodemographic, lifestyle, and mental health status variables were 27.2% for PCS and 23.4% for MCS. The R2 for Model 2 is the same for all clusters intragroup, as the regression models included a mutual adjustment between them

Association between clusters intra-groups of metabolic, cardiovascular, cardiovascular, and musculoskeletal conditions with the health related quality of life among individuals ≥20 years in South Australia, 2015 (N = 2912) Metabolic conditions: obesity, dyslipidaemia, and/or diabetes mellitus. Cardiovascular conditions: hypertension, myocardial infarction, angina, atrial fibrillation, heart failure, and/or stroke. Gastrointestinal conditions: irritable bowel syndrome, gastroesophageal reflux, coeliac disease, Chrohn’s disease and/or ulcerative colitis. Musculoskeletal conditions: osteoarthritis, gout and/or osteoporosis Model 1: predicted means adjusted for sex, age, marital status, area of residence, educational level, working status, socioeconomic position (Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged), fruit/vegetable consumption, physical activity, smoking status, alcohol intake, and mental health status Model 2: predicted means adjusted for variables in model 1 + mutual adjustment between the cluster intragroup of chronic conditions R2 = Determination coefficient in %. Adjusted R2 for models including just sociodemographic, lifestyle, and mental health status variables were 27.2% for PCS and 23.4% for MCS. The R2 for Model 2 is the same for all clusters intragroup, as the regression models included a mutual adjustment between them Table 4 shows the prevalence of clusters between-groups and their relationship with HRQoL. Only 41.0% of the participants were negative for all the investigated conditions, 25.2% were positive for only one group, and 3.1% were positive for the four groups. The most common two-group combinations were metabolic + cardiovascular (5.7%) and metabolic + musculoskeletal (5.5%), while for the three-group cluster the most frequent was metabolic + cardiovascular + musculoskeletal (8.3%). For PCS, in general, the higher the number of chronic conditions, the lower the score, both in crude and adjusted analysis (p < 0.001). Moreover, musculoskeletal conditions were a key group in these associations, as a lower PCS was observed in all clusters involving these diseases. PCS was 11.3 points lower (95%CI -14.0;-8.7) among those positives for all four groups of chronic conditions than among those negatives for all of them. On the other hand, no any specific pattern was observed for the association with MCS. The cluster gastrointestinal + musculoskeletal was the only combination associated with a lower score (−2.6 95%CI -5.2;0.0; p = 0.013) when compared to those negative for all the chronic conditions.
Table 4

Association between clusters between-groups of metabolic, cardiovascular, cardiovascular, and musculoskeletal conditions with the health related quality of life among individuals ≥20 years in South Australia, 2015

%Physical component scoreMental component score
CrudeAdjustedCrudeAdjusted
Mean (SE)Mean (SE)Mean (SE)Mean (SE)
No disease41.052.9 (0.3)52.7 (0.3)52.5 (0.3)52.6 (0.2)
One group only
Metabolic conditions11.050.0 (0.5)50.4 (0.5)52.5 (0.6)52.7 (0.5)
Cardiovascular conditions3.350.3 (0.8)51.5 (0.8)53.8 (0.7)52.5 (0.7)
Gastrointestinal conditions4.650.5 (0.9)50.1 (0.9)50.6 (0.9)51.2 (0.9)
Musculoskeletal conditions6.346.0 (0.8)47.0 (0.8)52.4 (0.7)52.5 (0.6)
Two-group clusters
Metabolic + Cardiovascular5.746.4 (0.9)48.4 (0.9)53.7 (0.7)52.6 (0.7)
Metabolic + Gastrointestinal1.947.6 (1.3)48.7 (1.6)49.2 (1.6)51.3 (1.1)
Metabolic + Musculoskeletal5.542.0 (1.0)43.7 (0.9)49.8 (0.9)50.7 (0.7)
Cardiovascular + Gastrointestinal1.048.9 (1.9)50.0 (1.6)52.3 (2.2)52.1 (2.1)
Cardiovascular + Musculoskeletal2.644.9 (1.2)47.9 (1.1)54.3 (0.7)52.8 (0.7)
Gastrointestinal + Musculoskeletal2.042.6 (1.5)44.2 (1.4)49.2 (1.4)49.9 (1.3)
Three-group clusters
Metabolic + Cardiovascular + Gastrointestinal1.444.3 (1.4)46.7 (1.3)52.5 (1.3)51.5 (1.2)
Metabolic + Cardiovascular + Musculoskeletal8.339.0 (0.7)41.8 (0.7)54.8 (0.5)53.5 (0.6)
Metabolic + Gastrointestinal + Musculoskeletal1.739.7 (1.3)41.8 (1.4)48.5 (1.5)51.2 (1.3)
Cardiovascular + Gastrointestinal + Musculoskeletal1.039.1 (1.6)42.6 (1.5)50.4 (1.8)50.7 (1.8)
Positives for the four groups3.138.2 (1.3)41.3 (1.3)53.0 (1.1)53.6 (1.1)
R 2 27.1% 36.7% 2.5% 24.2%

Metabolic conditions: obesity, dyslipidaemia, and/or diabetes mellitus. Cardiovascular conditions: hypertension, myocardial infarction, angina, atrial fibrillation, heart failure, and/or stroke. Gastrointestinal conditions: irritable bowel syndrome, gastroesophageal reflux, coeliac disease, Crohn’s disease and/or ulcerative colitis. Musculoskeletal conditions: osteoarthritis, gout and/or osteoporosis

R2 = Determination coefficient in %. Adjusted R2 for models including just sociodemographic, lifestyle, and mental health status variables were 27.2% for PCS and 23.4% for MCS

Model 1: predicted means adjusted for sex, age, marital status, area of residence, educational level, working status, socioeconomic position (Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged), fruit/vegetable consumption, physical activity, smoking status, alcohol intake, and mental health status

Model 2: predicted means adjusted for variables in model 1 + mutual adjustment between the cluster intragroup of chronic conditions

Association between clusters between-groups of metabolic, cardiovascular, cardiovascular, and musculoskeletal conditions with the health related quality of life among individuals ≥20 years in South Australia, 2015 Metabolic conditions: obesity, dyslipidaemia, and/or diabetes mellitus. Cardiovascular conditions: hypertension, myocardial infarction, angina, atrial fibrillation, heart failure, and/or stroke. Gastrointestinal conditions: irritable bowel syndrome, gastroesophageal reflux, coeliac disease, Crohn’s disease and/or ulcerative colitis. Musculoskeletal conditions: osteoarthritis, gout and/or osteoporosis R2 = Determination coefficient in %. Adjusted R2 for models including just sociodemographic, lifestyle, and mental health status variables were 27.2% for PCS and 23.4% for MCS Model 1: predicted means adjusted for sex, age, marital status, area of residence, educational level, working status, socioeconomic position (Socio-Economic Indexes for Areas Index of Relative Socio-economic Advantage and Disadvantaged), fruit/vegetable consumption, physical activity, smoking status, alcohol intake, and mental health status Model 2: predicted means adjusted for variables in model 1 + mutual adjustment between the cluster intragroup of chronic conditions Compared to the model including just sociodemographic, lifestyle, and mental health status variables (adjusted R2 = 27.2%), there was an increment of 35–40% in the variability of PCS explained by the chronic conditions, with small differences between models including individual chronic conditions (adjusted R2 = 38.1%), clusters within-group (adjusted R2 = 36.9%), or clusters between-group (adjusted R2 = 36.7%). For the mental HRQoL, the adjusted R2 for the regression model including just the covariates (23.4%) remained relatively stable after including the chronic conditions (24.4%, 24.1%, and 24.2%, respectively). No evidence of multicollinearity between the explanatory variables was identified, as the mean VIF did not exceed 1.62 in any model.

Discussion

To our knowledge, this is the first study investigating multimorbidity using clinically relevant clusters of chronic conditions. Four main findings can be highlighted based on our results. Firstly, chronic conditions, either individually or in clusters (within- or between-group), were consistently associated with a lower PCS, but the relationship with MCS was subtle. Secondly, regarding individual diseases, the lowest PCS was observed among those with stroke, heart failure and osteoarthritis; better management of osteoarthritis could therefore have a positive public health impact, considering its reported high prevalence. Thirdly, direct-trend relationships were observed between the number of chronic conditions (clusters within- and between-groups) and PCS. Finally, musculoskeletal conditions are particularly relevant in these associations, not only because they showed the lowest PCS among the clusters within-group, but because lower scores were also observed in any combination of clusters between-group including musculoskeletal diseases. The negative correlation between multimorbidity and PCS but not with MCS observed in our study is consistent with the findings of a systematic review published in 2004 [4]. All of the 27 studies included in that review found an inverse trend relationship between the number of chronic conditions and PCS, but the association with MCS was inconclusive. Additionally, a study involving representative samples from eight high-income countries (Denmark, France, Germany, Italy, Japan, The Netherlands, Norway and the United States) investigated from 1990 to1996, reported that chronic diseases had a stronger association with PCS than with MCS [27]. In agreement with our results, arthritis and heart failure were two of the conditions highly correlated with PCS (−4.5 and −4.4, respectively). More recent population-based studies conducted in different income settings and aiming to investigate the relationship between multimorbidity and HRQoL identified similar findings [9, 28]. Therefore, the increasing prevalence of chronic diseases [1, 29] in SA during the last two decades could explain the progressive reduction in PCS [from 49.8 (95%CI 49.4–50.2) in 1997 to 48.6 (95%CI 48.2–49.0) in 2015], while MCS has remained constant [30]. This hypothesis should be explored in future longitudinal studies. These results suggest new challenges for the Australian health care system, considering HRQoL is closely related to the adherence to health management, hospitalisations, and mortality among individuals affected by chronic conditions [6, 9]. Health indicators for Australia are strong and the country has one of the longest life expectancies among high-income economies, largely due the universal access to a comprehensive range of services (i.e. general practice, community and emergency health services, hospital care, rehabilitation and palliative care, prescriptions) provided by Medicare and the national health care system [13, 31]. Nevertheless, similar to other developed countries, there are concerns about the future of this publicly funded health service, considering the ageing of the population, rising levels of obesity, and the increasing burden of chronic conditions [1, 29, 31]. In this sense, among the investigated chronic diseases, musculoskeletal conditions seem to be a key group that determines PCS. When investigating clusters within-group, the regression coefficients for the association between these conditions and PCS were 46% higher than for cardiovascular diseases, and twice the value of gastrointestinal and metabolic conditions. For the clusters between-group, PCS was at least four points lower in all combinations including musculoskeletal conditions, compared to those combinations without them. These results are consistent with the findings of two surveys conducted in Spain (1999–2000) [32] and the Netherlands (2010) [33]. According to these studies, musculoskeletal conditions amplified the negative association between multimorbidity and PCS but not with MCS, irrespective of the number of other chronic conditions. These findings are particularly relevant in terms of public health, considering musculoskeletal diseases affect between 10%–35% of the population over the age of 35 years, and have become a leading cause for years lived with disability (YLDs) and Disability-adjusted life years (DALYs) in the last 30 years [34, 35]. Additionally, musculoskeletal conditions are responsible for a two-fold increase in healthcare costs, which is the second highest increase after cancer [33]. Finally, although the assessment of the associations between multimorbidity and HRQoL (variation in the scores based on the R2) was better explained in the model including the individual conditions than the clusters, within- or between-group, the differences in R2 were small. Furthermore, the latter approach considering all the combinations of clusters between-group seems more relevant for clinical practice, as it allows identification of the combinations most strongly associated with a lower HRQoL. Some limitations should be discussed. Firstly, the diagnosis of chronic health conditions and behavioural risk factors was by self-report. Although reliable and highly specific [36, 37], the validity of this information is reduced by intermediate levels of sensitivity (ranging from 33 to 85%) [37]. However, this possible source of bias is less likely to explain our results, as it would have reduced the magnitude of the associations. Secondly, the assessment of HRQoL was probably compromised among individuals with mental health conditions, as their judgment regarding subjective outcomes, such as well-being and/or satisfaction with their life, are usually lower compared to the assessment by an independent observer (affective fallacy bias) [20, 25]. However, to reduce confounding in the associations introduced by this bias, all results were adjusted for mental health status. Although some residual confounding may be expected as mental health status was quantified using one specific question, it is unlikely this analytical procedure explains the lack of association with MCS, as the VIF was low and excluding that variable from the analyses did not affect the statistical significance or direction of the associations (results not shown). Thirdly, 29% of the eligible participants refused to participate in the study. For ethical reasons, no any information was collected from these individuals, restraining us of assessing non-response bias. Nonetheless, the distribution of the evaluated sample according to sociodemographic variables is comparable to the available data for SA in the last Australian census [13]. Finally, causal inferences are not possible due to the cross-sectional design of this study.

Conclusions

Chronic conditions are not only highly prevalent in the population, but they cluster in individuals. Furthermore, the relationship between multimorbidity and HRQoL is not only additive, as the coexistence of musculoskeletal conditions amplifies the association of other diseases with PCS. Our findings highlight the need for innovation in the management of patients with chronic health conditions, as active checking for comorbidities that cluster frequently may help identify individuals with reduced physical HRQoL. Therefore, it seems that a multidisciplinary approach might be more effective than focussing on single health conditions to improve HRQoL and promote healthy ageing. Further longitudinal studies will be necessary to elucidate the real impact of different clusters of chronic conditions on the different domains of HRQoL.
  28 in total

1.  Rethinking and rescoring the SF-12.

Authors:  David Wilson; Graeme Tucker; Catherine Chittleborough
Journal:  Soz Praventivmed       Date:  2002

2.  Comorbidity and guidelines: conflicting interests.

Authors:  Chris van Weel; François G Schellevis
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321

3.  Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease.

Authors:  Estíbaliz Loza; Juan A Jover; Luis Rodriguez; Loreto Carmona
Journal:  Semin Arthritis Rheum       Date:  2008-03-12       Impact factor: 5.532

4.  Lower educational level and unemployment increase the impact of cardiometabolic conditions on the quality of life: results of a population-based study in South Australia.

Authors:  David Alejandro González-Chica; Robert Adams; Eleonora Dal Grande; Jodie Avery; Phillipa Hay; Nigel Stocks
Journal:  Qual Life Res       Date:  2017-02-11       Impact factor: 4.147

5.  Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project.

Authors:  Jordi Alonso; Montserrat Ferrer; Barbara Gandek; John E Ware; Neil K Aaronson; Paola Mosconi; Niels K Rasmussen; Monika Bullinger; Shunichi Fukuhara; Stein Kaasa; Alain Leplège
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

6.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

7.  Predictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care.

Authors:  Sabine Ludt; Michel Wensing; Joachim Szecsenyi; Jan van Lieshout; Justine Rochon; Tobias Freund; Stephen M Campbell; Dominik Ose
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

8.  Ten-year trends in major lifestyle risk factors using an ongoing population surveillance system in Australia.

Authors:  Anne W Taylor; Eleonora Dal Grande; Jing Wu; Zumin Shi; Stefano Campostrini
Journal:  Popul Health Metr       Date:  2014-10-30

9.  Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.

Authors:  Christopher J L Murray; Ryan M Barber; Kyle J Foreman; Ayse Abbasoglu Ozgoren; Foad Abd-Allah; Semaw F Abera; Victor Aboyans; Jerry P Abraham; Ibrahim Abubakar; Laith J Abu-Raddad; Niveen M Abu-Rmeileh; Tom Achoki; Ilana N Ackerman; Zanfina Ademi; Arsène K Adou; José C Adsuar; Ashkan Afshin; Emilie E Agardh; Sayed Saidul Alam; Deena Alasfoor; Mohammed I Albittar; Miguel A Alegretti; Zewdie A Alemu; Rafael Alfonso-Cristancho; Samia Alhabib; Raghib Ali; François Alla; Peter Allebeck; Mohammad A Almazroa; Ubai Alsharif; Elena Alvarez; Nelson Alvis-Guzman; Azmeraw T Amare; Emmanuel A Ameh; Heresh Amini; Walid Ammar; H Ross Anderson; Benjamin O Anderson; Carl Abelardo T Antonio; Palwasha Anwari; Johan Arnlöv; Valentina S Arsic Arsenijevic; Al Artaman; Rana J Asghar; Reza Assadi; Lydia S Atkins; Marco A Avila; Baffour Awuah; Victoria F Bachman; Alaa Badawi; Maria C Bahit; Kalpana Balakrishnan; Amitava Banerjee; Suzanne L Barker-Collo; Simon Barquera; Lars Barregard; Lope H Barrero; Arindam Basu; Sanjay Basu; Mohammed O Basulaiman; Justin Beardsley; Neeraj Bedi; Ettore Beghi; Tolesa Bekele; Michelle L Bell; Corina Benjet; Derrick A Bennett; Isabela M Bensenor; Habib Benzian; Eduardo Bernabé; Amelia Bertozzi-Villa; Tariku J Beyene; Neeraj Bhala; Ashish Bhalla; Zulfiqar A Bhutta; Kelly Bienhoff; Boris Bikbov; Stan Biryukov; Jed D Blore; Christopher D Blosser; Fiona M Blyth; Megan A Bohensky; Ian W Bolliger; Berrak Bora Başara; Natan M Bornstein; Dipan Bose; Soufiane Boufous; Rupert R A Bourne; Lindsay N Boyers; Michael Brainin; Carol E Brayne; Alexandra Brazinova; Nicholas J K Breitborde; Hermann Brenner; Adam D Briggs; Peter M Brooks; Jonathan C Brown; Traolach S Brugha; Rachelle Buchbinder; Geoffrey C Buckle; Christine M Budke; Anne Bulchis; Andrew G Bulloch; Ismael R Campos-Nonato; Hélène Carabin; Jonathan R Carapetis; Rosario Cárdenas; David O Carpenter; Valeria Caso; Carlos A Castañeda-Orjuela; Ruben E Castro; Ferrán Catalá-López; Fiorella Cavalleri; Alanur Çavlin; Vineet K Chadha; Jung-Chen Chang; Fiona J Charlson; Honglei Chen; Wanqing Chen; Peggy P Chiang; Odgerel Chimed-Ochir; Rajiv Chowdhury; Hanne Christensen; Costas A Christophi; Massimo Cirillo; Matthew M Coates; Luc E Coffeng; Megan S Coggeshall; Valentina Colistro; Samantha M Colquhoun; Graham S Cooke; Cyrus Cooper; Leslie T Cooper; Luis M Coppola; Monica Cortinovis; Michael H Criqui; John A Crump; Lucia Cuevas-Nasu; Hadi Danawi; Lalit Dandona; Rakhi Dandona; Emily Dansereau; Paul I Dargan; Gail Davey; Adrian Davis; Dragos V Davitoiu; Anand Dayama; Diego De Leo; Louisa Degenhardt; Borja Del Pozo-Cruz; Robert P Dellavalle; Kebede Deribe; Sarah Derrett; Don C Des Jarlais; Muluken Dessalegn; Samath D Dharmaratne; Mukesh K Dherani; Cesar Diaz-Torné; Daniel Dicker; Eric L Ding; Klara Dokova; E Ray Dorsey; Tim R Driscoll; Leilei Duan; Herbert C Duber; Beth E Ebel; Karen M Edmond; Yousef M Elshrek; Matthias Endres; Sergey P Ermakov; Holly E Erskine; Babak Eshrati; Alireza Esteghamati; Kara Estep; Emerito Jose A Faraon; Farshad Farzadfar; Derek F Fay; Valery L Feigin; David T Felson; Seyed-Mohammad Fereshtehnejad; Jefferson G Fernandes; Alize J Ferrari; Christina Fitzmaurice; Abraham D Flaxman; Thomas D Fleming; Nataliya Foigt; Mohammad H Forouzanfar; F Gerry R Fowkes; Urbano Fra Paleo; Richard C Franklin; Thomas Fürst; Belinda Gabbe; Lynne Gaffikin; Fortuné G Gankpé; Johanna M Geleijnse; Bradford D Gessner; Peter Gething; Katherine B Gibney; Maurice Giroud; Giorgia Giussani; Hector Gomez Dantes; Philimon Gona; Diego González-Medina; Richard A Gosselin; Carolyn C Gotay; Atsushi Goto; Hebe N Gouda; Nicholas Graetz; Harish C Gugnani; Rahul Gupta; Rajeev Gupta; Reyna A Gutiérrez; Juanita Haagsma; Nima Hafezi-Nejad; Holly Hagan; Yara A Halasa; Randah R Hamadeh; Hannah Hamavid; Mouhanad Hammami; Jamie Hancock; Graeme J Hankey; Gillian M Hansen; Yuantao Hao; Hilda L Harb; Josep Maria Haro; Rasmus Havmoeller; Simon I Hay; Roderick J Hay; Ileana B Heredia-Pi; Kyle R Heuton; Pouria Heydarpour; Hideki Higashi; Martha Hijar; Hans W Hoek; Howard J Hoffman; H Dean Hosgood; Mazeda Hossain; Peter J Hotez; Damian G Hoy; Mohamed Hsairi; Guoqing Hu; Cheng Huang; John J Huang; Abdullatif Husseini; Chantal Huynh; Marissa L Iannarone; Kim M Iburg; Kaire Innos; Manami Inoue; Farhad Islami; Kathryn H Jacobsen; Deborah L Jarvis; Simerjot K Jassal; Sun Ha Jee; Panniyammakal Jeemon; Paul N Jensen; Vivekanand Jha; Guohong Jiang; Ying Jiang; Jost B Jonas; Knud Juel; Haidong Kan; André Karch; Corine K Karema; Chante Karimkhani; Ganesan Karthikeyan; Nicholas J Kassebaum; Anil Kaul; Norito Kawakami; Konstantin Kazanjan; Andrew H Kemp; Andre P Kengne; Andre Keren; Yousef S Khader; Shams Eldin A Khalifa; Ejaz A Khan; Gulfaraz Khan; Young-Ho Khang; Christian Kieling; Daniel Kim; Sungroul Kim; Yunjin Kim; Yohannes Kinfu; Jonas M Kinge; Miia Kivipelto; Luke D Knibbs; Ann Kristin Knudsen; Yoshihiro Kokubo; Soewarta Kosen; Sanjay Krishnaswami; Barthelemy Kuate Defo; Burcu Kucuk Bicer; Ernst J Kuipers; Chanda Kulkarni; Veena S Kulkarni; G Anil Kumar; Hmwe H Kyu; Taavi Lai; Ratilal Lalloo; Tea Lallukka; Hilton Lam; Qing Lan; Van C Lansingh; Anders Larsson; Alicia E B Lawrynowicz; Janet L Leasher; James Leigh; Ricky Leung; Carly E Levitz; Bin Li; Yichong Li; Yongmei Li; Stephen S Lim; Maggie Lind; Steven E Lipshultz; Shiwei Liu; Yang Liu; Belinda K Lloyd; Katherine T Lofgren; Giancarlo Logroscino; Katharine J Looker; Joannie Lortet-Tieulent; Paulo A Lotufo; Rafael Lozano; Robyn M Lucas; Raimundas Lunevicius; Ronan A Lyons; Stefan Ma; Michael F Macintyre; Mark T Mackay; Marek Majdan; Reza Malekzadeh; Wagner Marcenes; David J Margolis; Christopher Margono; Melvin B Marzan; Joseph R Masci; Mohammad T Mashal; Richard Matzopoulos; Bongani M Mayosi; Tasara T Mazorodze; Neil W Mcgill; John J Mcgrath; Martin Mckee; Abigail Mclain; Peter A Meaney; Catalina Medina; Man Mohan Mehndiratta; Wubegzier Mekonnen; Yohannes A Melaku; Michele Meltzer; Ziad A Memish; George A Mensah; Atte Meretoja; Francis A Mhimbira; Renata Micha; Ted R Miller; Edward J Mills; Philip B Mitchell; Charles N Mock; Norlinah Mohamed Ibrahim; Karzan A Mohammad; Ali H Mokdad; Glen L D Mola; Lorenzo Monasta; Julio C Montañez Hernandez; Marcella Montico; Thomas J Montine; Meghan D Mooney; Ami R Moore; Maziar Moradi-Lakeh; Andrew E Moran; Rintaro Mori; Joanna Moschandreas; Wilkister N Moturi; Madeline L Moyer; Dariush Mozaffarian; William T Msemburi; Ulrich O Mueller; Mitsuru Mukaigawara; Erin C Mullany; Michele E Murdoch; Joseph Murray; Kinnari S Murthy; Mohsen Naghavi; Aliya Naheed; Kovin S Naidoo; Luigi Naldi; Devina Nand; Vinay Nangia; K M Venkat Narayan; Chakib Nejjari; Sudan P Neupane; Charles R Newton; Marie Ng; Frida N Ngalesoni; Grant Nguyen; Muhammad I Nisar; Sandra Nolte; Ole F Norheim; Rosana E Norman; Bo Norrving; Luke Nyakarahuka; In-Hwan Oh; Takayoshi Ohkubo; Summer L Ohno; Bolajoko O Olusanya; John Nelson Opio; Katrina Ortblad; Alberto Ortiz; Amanda W Pain; Jeyaraj D Pandian; Carlo Irwin A Panelo; Christina Papachristou; Eun-Kee Park; Jae-Hyun Park; Scott B Patten; George C Patton; Vinod K Paul; Boris I Pavlin; Neil Pearce; David M Pereira; Rogelio Perez-Padilla; Fernando Perez-Ruiz; Norberto Perico; Aslam Pervaiz; Konrad Pesudovs; Carrie B Peterson; Max Petzold; Michael R Phillips; Bryan K Phillips; David E Phillips; Frédéric B Piel; Dietrich Plass; Dan Poenaru; Suzanne Polinder; Daniel Pope; Svetlana Popova; Richie G Poulton; Farshad Pourmalek; Dorairaj Prabhakaran; Noela M Prasad; Rachel L Pullan; Dima M Qato; D Alex Quistberg; Anwar Rafay; Kazem Rahimi; Sajjad U Rahman; Murugesan Raju; Saleem M Rana; Homie Razavi; K Srinath Reddy; Amany Refaat; Giuseppe Remuzzi; Serge Resnikoff; Antonio L Ribeiro; Lee Richardson; Jan Hendrik Richardus; D Allen Roberts; David Rojas-Rueda; Luca Ronfani; Gregory A Roth; Dietrich Rothenbacher; David H Rothstein; Jane T Rowley; Nobhojit Roy; George M Ruhago; Mohammad Y Saeedi; Sukanta Saha; Mohammad Ali Sahraian; Uchechukwu K A Sampson; Juan R Sanabria; Logan Sandar; Itamar S Santos; Maheswar Satpathy; Monika Sawhney; Peter Scarborough; Ione J Schneider; Ben Schöttker; Austin E Schumacher; David C Schwebel; James G Scott; Soraya Seedat; Sadaf G Sepanlou; Peter T Serina; Edson E Servan-Mori; Katya A Shackelford; Amira Shaheen; Saeid Shahraz; Teresa Shamah Levy; Siyi Shangguan; Jun She; Sara Sheikhbahaei; Peilin Shi; Kenji Shibuya; Yukito Shinohara; Rahman Shiri; Kawkab Shishani; Ivy Shiue; Mark G Shrime; Inga D Sigfusdottir; Donald H Silberberg; Edgar P Simard; Shireen Sindi; Abhishek Singh; Jasvinder A Singh; Lavanya Singh; Vegard Skirbekk; Erica Leigh Slepak; Karen Sliwa; Samir Soneji; Kjetil Søreide; Sergey Soshnikov; Luciano A Sposato; Chandrashekhar T Sreeramareddy; Jeffrey D Stanaway; Vasiliki Stathopoulou; Dan J Stein; Murray B Stein; Caitlyn Steiner; Timothy J Steiner; Antony Stevens; Andrea Stewart; Lars J Stovner; Konstantinos Stroumpoulis; Bruno F Sunguya; Soumya Swaminathan; Mamta Swaroop; Bryan L Sykes; Karen M Tabb; Ken Takahashi; Nikhil Tandon; David Tanne; Marcel Tanner; Mohammad Tavakkoli; Hugh R Taylor; Braden J Te Ao; Fabrizio Tediosi; Awoke M Temesgen; Tara Templin; Margreet Ten Have; Eric Y Tenkorang; Abdullah S Terkawi; Blake Thomson; Andrew L Thorne-Lyman; Amanda G Thrift; George D Thurston; Taavi Tillmann; Marcello Tonelli; Fotis Topouzis; Hideaki Toyoshima; Jefferson Traebert; Bach X Tran; Matias Trillini; Thomas Truelsen; Miltiadis Tsilimbaris; Emin M Tuzcu; Uche S Uchendu; Kingsley N Ukwaja; Eduardo A Undurraga; Selen B Uzun; Wim H Van Brakel; Steven Van De Vijver; Coen H van Gool; Jim Van Os; Tommi J Vasankari; N Venketasubramanian; Francesco S Violante; Vasiliy V Vlassov; Stein Emil Vollset; Gregory R Wagner; Joseph Wagner; Stephen G Waller; Xia Wan; Haidong Wang; Jianli Wang; Linhong Wang; Tati S Warouw; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Wang Wenzhi; Andrea Werdecker; Ronny Westerman; Harvey A Whiteford; James D Wilkinson; Thomas N Williams; Charles D Wolfe; Timothy M Wolock; Anthony D Woolf; Sarah Wulf; Brittany Wurtz; Gelin Xu; Lijing L Yan; Yuichiro Yano; Pengpeng Ye; Gökalp K Yentür; Paul Yip; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Z Younis; Chuanhua Yu; Maysaa E Zaki; Yong Zhao; Yingfeng Zheng; David Zonies; Xiaonong Zou; Joshua A Salomon; Alan D Lopez; Theo Vos
Journal:  Lancet       Date:  2015-08-28       Impact factor: 79.321

10.  Reliability of self-reported health risk factors and chronic conditions questions collected using the telephone in South Australia, Australia.

Authors:  Eleonora Dal Grande; Simon Fullerton; Anne W Taylor
Journal:  BMC Med Res Methodol       Date:  2012-07-26       Impact factor: 4.615

View more
  10 in total

1.  Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population.

Authors:  Elizabeth Riley; Jongwha Chang; Chanhyun Park; Sean Kim; Inho Song
Journal:  Clin Drug Investig       Date:  2019-09       Impact factor: 2.859

2.  Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors.

Authors:  Nigel P Stocks; David A González-Chica; Robyn L Woods; Jessica E Lockery; Rory S J Wolfe; Anne M Murray; Brenda Kirpach; Raj C Shah; Mark R Nelson; Christopher M Reid; Michael E Ernst; John J McNeil
Journal:  Qual Life Res       Date:  2018-11-08       Impact factor: 4.147

3.  Multiple comorbid conditions and healthcare resource utilization among adult patients with hyperkalemia: A retrospective observational cohort study using association rule mining.

Authors:  Dingwei Dai; Ajay Sharma; Paula J Alvarez; Steven D Woods
Journal:  J Multimorb Comorb       Date:  2022-05-12

4.  Gout, flares, and allopurinol use: a population-based study.

Authors:  Charlotte Proudman; Susan E Lester; David A Gonzalez-Chica; Tiffany K Gill; Nicola Dalbeth; Catherine L Hill
Journal:  Arthritis Res Ther       Date:  2019-05-31       Impact factor: 5.156

5.  Data mining to understand health status preceding traumatic brain injury.

Authors:  Tatyana Mollayeva; Mitchell Sutton; Vincy Chan; Angela Colantonio; Sayantee Jana; Michael Escobar
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

6.  The Joint Effect of Physical Multimorbidity and Mental Health Conditions Among Adults in Australia.

Authors:  Marie Ishida; Emily Sg Hulse; Robert K Mahar; Jane Gunn; Rifat Atun; Barbara McPake; Naveen Tenneti; Kanya Anindya; Gregory Armstrong; Patrick Mulcahy; Will Carman; John Tayu Lee
Journal:  Prev Chronic Dis       Date:  2020-12-10       Impact factor: 2.830

7.  Trends in long-term opioid prescriptions for musculoskeletal conditions in Australian general practice: a national longitudinal study using MedicineInsight, 2012-2018.

Authors:  Sean Black-Tiong; David Gonzalez-Chica; Nigel Stocks
Journal:  BMJ Open       Date:  2021-04-07       Impact factor: 2.692

8.  Cross-sectional evaluation of the interaction between activity relative-time expenditure and comorbidity concerning physical quality of life.

Authors:  Rafael Suarez-Villar; Diego Martinez-Urbistondo; Maria Agud Fernandez; Maria Lopez-Cano; Eva Fernandez; Andrea Dominguez; Laura Prosper; Ana Rodriguez-Cobo; Maria Elena Caro Tinoco; Paula Nadal; Carlos Risco Risco; Paula Villares Fernández; Jose Alfredo Martínez
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

9.  Association of anthropometric indices with the development of multimorbidity in middle-aged and older adults: A retrospective cohort study.

Authors:  Shuoji Geng; Xuejiao Chen; Zhan Shi; Kaizhi Bai; Songhe Shi
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

10.  Exercise Training for Patients With Severe Aortic Stenosis in a Convalescent Rehabilitation Ward - A Retrospective Cohort Study.

Authors:  Hideki Arai; Masafumi Nozoe; Satoru Matsumoto; Takeshi Morimoto
Journal:  Circ Rep       Date:  2021-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.